Kezarlifesciences
Kezar is a clinical-stage biopharmaceutical company that engages in developing novel small molecule therapeutics for autoimmune diseases.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Kezarlifesciences Information
Geographic Data
Address: 300 Utah Ave Ste 105
City: South San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$50M
Raised Total:$123M
Social
Metrics
3,594,928Website Global Rank
3,751Website Monthly Traffic
Twitter Followers
Description
Kezar is a clinical-stage biopharmaceutical company that engages in developing novel small molecule therapeutics for autoimmune diseases.
Contact Phone:
+16508225600
Contact Email:
Kezarlifesciences went public on 6/20/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/20/2018
Ticker Symbol:
KZR
IPO Price:
$15/share
Amount Raised:
$75M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
